Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 2Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 9Gastrointestinal 3NET 2Thoracic 1Dermatologic 1CNS 1

Conditions

Melanoma 323Skin Neoplasms 164Carcinoma, Basal Cell 90Keratosis, Actinic 62Lymphoma, T-Cell, Cutaneous 60Breast Neoplasms 59Leukemia, Lymphocytic, Chronic, B-Cell 47Precursor Cell Lymphoblastic Leukemia-Lymphoma 46Mycosis Fungoides 46Lymphoma, Non-Hodgkin 46Sezary Syndrome 44Lymphoma, Follicular 44Lymphoma, Large B-Cell, Diffuse 43Lymphoma, B-Cell, Marginal Zone 43Lymphoma, Mantle-Cell 42Burkitt Lymphoma 42Hodgkin Disease 41Carcinoma, Squamous Cell 41Lymphoma, Large-Cell, Immunoblastic 40Neoplasms 39Multiple Myeloma 39Lymphoma 39Leukemia, Myeloid, Acute 35Leukemia, Myeloid, Accelerated Phase 32Myeloproliferative Disorders 31Leukemia, Myeloid, Chronic-Phase 31Congenital Abnormalities 30Leukemia, Hairy Cell 29Sarcoma 28Primary Myelofibrosis 28

Interventions

Aromatherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Carcinoma, Neuroendocrine × Dermatologic × Clear all
NCT03858855 2020-08-04

Inhaled Essential Oil Effect on Common QOL Concerns During Cancer Treatment

Ohio State University Comprehensive Cancer Center

Phase NA Completed
248 enrolled
DermatologicEndocrineGastrointestinal

Gastrointestinal Neoplasms, Melanoma, Skin Neoplasms, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡